Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?

BJU International

Volumn 111, Issue 4, 2013, Pages 672-682

  Bennett, Haley L ^a   Stockley, Jacqueline ^b   Fleming, Janis T ^a   Mandal, Ranadip ^a   O'Prey, Jim ^a   Ryan, Kevin M ^a   Robson, Craig N ^b   Leung, Hing Y ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

androgen ablation therapy; autophagy; chemotherapy

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; DOCETAXEL; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN LC3; UNCLASSIFIED DRUG;

ABLATION THERAPY; ANDROGEN THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER CELL; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOPHAGY; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; NITRILES; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; SENSITIVITY AND SPECIFICITY; TAXOIDS; TOSYL COMPOUNDS;

EID: 84875874119     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11409.x     Document Type: Article

References (52)

1. Knudsen KE, Scher HI,. Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer. Clin Cancer Res 2009; 15: 4792-4798
2. Hodgson MC, Astapova I, Hollenberg AN, Balk SP,. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Cancer Res 2007; 67: 8388-8395
3. Cohen MB, Rokhlin OW,. Mechanisms of prostate cancer cell survival after inhibition of AR expression. J Cell Biochem 2009; 106: 363-371
4. Lee EC, Zhan P, Schallhom R, Packman K, Tenniswood M,. Antiandrogen-induced cell death in LNCaP human prostate cancer cells. Cell Death Differ 2003; 10: 761-771
5. Petrylak DP, Tangen CM, Hussain MH, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004; 351: 1513-1520
6. Tannock IF, de Wit R, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351: 1502-1512
7. Shalli K, Brown I, Heys SD, Schofield AC,. Alterations of beta-tubulin isotypes in breast cancer cells resistant to docetaxel. FASEB J 2005; 19: 1299-1301
8. Manavathi B, Acconcia F, Rayala SK, Kumar R,. An inherent role of microtubule network in the action of nuclear receptor. Proc Natl Acad Sci U S A 2006; 103: 15981-15986
9. Kondo Y, Kanzawa T, Sawaya R, Kondo S,. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5: 726-734
10. Levine B., Cell biology: autophagy and cancer. Nature 2007; 446: 745-747
11. White E, DiPaola RS., The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15: 5308-5316
12. Lomonaco SL, Finniss S, Xiang C, et al. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer 2009; 125: 717-722
13. Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA., Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. Plos ONE 2009; 4: e6251
14. Bennett HL, Fleming JT, O'Prey J, Ryan KM, Leung HY., Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells. Cell Death Dis 2010; 1: e72
15. Leake R, Ri, Munir I., Steroid Responses in Vivo and in Vitro. Steroid Hormones: A Practical Approach. Washington, DC: IRL Press, 1987
16. Halkidou K, Gnanapragasam VJ, Mehta PB, et al. Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene 2003; 22: 2466-2477
17. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-1112
18. Mizushima N, Yoshimori T,. How to interpret LC3 immunoblotting. Autophagy 2007; 3: 542-545
19. Xu Y, Chen SY, Ross KN, Balk SP,. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res 2006; 66: 7783-7792
20. Cinar B, Mukhopadhyay NK, Meng G, Freeman MR,. Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains. J Biol Chem 2007; 282: 29584-29593
21. Diaz-Troya S, Perez-Perez ME, Florencio FJ, Crespo JL., The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy 2008; 4: 851-865
22. Wolf DA, Herzinger T, Hermeking H, Blaschke D, Horz W,. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol Endocrinol 1993; 7: 924-936
23. Yuan TC, Veeramani S, Lin FF, et al. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocr Relat Cancer 2006; 13: 151-167
24. Korolchuk VI, Saiki S, Lichtenberg M, et al. Lysosomal positioning coordinates cellular nutrient responses. Nat Cell Biol 2011; 13: 453-460
25. Scarlatti F, Granata R, Meijer AJ, Codogno P,. Does autophagy have a license to kill mammalian cells? Cell Death Differ 2009; 16: 12-20
26. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C,. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 2002; 21: 4037-4048
27. Chen JG, Yang CP, Cammer M, Horwitz SB,. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 2003; 63: 7891-7899
28. Au JL, Kumar RR, Li D, Wientjes MG,. Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis. AAPS PharmSci 1999; 1: E8
29. Li Y, Li X, Hussain M, Sarkar FH,. Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray. Neoplasia 2004; 6: 158-167
30. Nehme A, Varadarajan P, Sellakumar G, et al. Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells. Br J Cancer 2001; 84: 1571-1576
31. Gascoigne KE, Taylor SS,. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008; 14: 111-122
32. Petrylak DP., Future directions in the treatment of androgen-independent prostate cancer. Urology 2005; 65: 8-12
33. Petrylak DP., The current role of chemotherapy in metastatic hormone-refractory prostate cancer. Urology 2005; 65: 3-8
34. Hess-Wilson JK, Daly HK, Zagorski WA, Montville CP, Knudsen KE., Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult. Cancer Res 2006; 66: 11998-12008
35. Shamash J, Davies A, Ansell W, et al. A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer. Br J Cancer 2008; 98: 22-24
36. Shamash J, Dancey G, Barlow C, Wilson P, Ansell W, Oliver RT,. Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding. Br J Cancer 2005; 92: 36-40
37. Cox RA, Sundar S,. Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy. Br J Cancer 2008; 98: 238-239
38. Akner G, Sundqvist KG, Denis M, Wikstrom AC, Gustafsson JA,. Immunocytochemical localization of glucocorticoid receptor in human gingival fibroblasts and evidence for a colocalization of glucocorticoid receptor with cytoplasmic microtubules. Eur J Cell Biol 1990; 53: 390-401
39. Vorgias CE, Perides GA, Traub P, Sekeris CE,. Colchicine, colcemide and cytochalasin B do not affect translocation of the glucocorticoid hormone-receptor in rat thymocytes or Ehrlich ascites cells. Biosci Rep 1988; 8: 193-197
40. Akner G, Wikstrom AC, Stromstedt PE, Stockman O, Gustafsson JA, Wallin M,. Glucocorticoid receptor inhibits microtubule assembly in vitro. Mol Cell Endocrinol 1995; 110: 49-54
41. Akner G, Mossberg K, Sundqvist KG, Gustafsson JA, Wikstrom AC,. Evidence for reversible, non-microtubule and non-microfilament-dependent nuclear translocation of hsp90 after heat shock in human fibroblasts. Eur J Cell Biol 1992; 58: 356-364
42. Ozanne DM, Brady ME, Cook S, Gaughan L, Neal DE, Robson CN,. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol Endocrinol 2000; 14: 1618-1626
43. Gan L, Chen S, Wang Y, et al. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer. Cancer Res 2009; 69: 8386-8394
44. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM., Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010; 141: 290-303
45. Jahreiss L, Menzies FM, Rubinsztein DC,. The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes. Traffic 2008; 9: 574-587
46. Kimura S, Noda T, Yoshimori T,. Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct Funct 2008; 33: 109-122
47. Cardoso CM, Groth-Pedersen L, Hoyer-Hansen M, et al. Depletion of kinesin 5B affects lysosomal distribution and stability and induces peri-nuclear accumulation of autophagosomes in cancer cells. Plos ONE 2009; 4: e4424
48. Steffan JJ, Williams BC, Welbourne T, Cardelli JA., HGF-induced invasion by prostate tumor cells requires anterograde lysosome trafficking and activity of Na+-H+ exchangers. J Cell Sci 2010; 123: 1151-1159
49. Colello D, Reverte CG, Ward R, et al. Androgen and Src signaling regulate centrosome activity. J Cell Sci 2010; 123: 2094-2102
50. Hu L, Roth JM, Brooks P, Luty J, Karpatkin S,. Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. Cancer Res 2008; 68: 4666-4673
51. Zheng X, Chu F, Chou PM, et al. Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism. Am J Physiol Cell Physiol 2009; 296: C65-74
52. Saftig P, Klumperman J,. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 2009; 10: 623-635